JAVELIN: avelumab another spear to fight urothelial carcinoma
Journal Articles
- Overview
- Research
- Identity
- Additional Document Info
- View All
Overview
status
publication date
- January 2018
has subject area
- 1112 Oncology and Carcinogenesis (FoR)
- Antibodies, Monoclonal (MeSH)
- Antibodies, Monoclonal, Humanized (MeSH)
- Carcinoma, Transitional Cell (MeSH)
- Humans (MeSH)
- Oncology & Carcinogenesis (Science Metrix)
- Urologic Neoplasms (MeSH)
published in
- The Lancet Oncology Journal